Evaluating a Mental Health Digital Intervention for Dads
Launched by MCGILL UNIVERSITY · Mar 6, 2025
Trial Information
Current as of May 10, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a digital program called HealthyDads, designed to support fathers who may be experiencing mental health challenges during their partner's pregnancy or after childbirth. It aims to provide helpful information and strategies to reduce stress, improve parenting skills, and promote healthy living for expectant dads who might be at risk for depression. The goal is to see how well fathers respond to this online resource and whether it meets their needs.
To participate, fathers-to-be must live in Canada, speak either English or French, and have a partner who is between 14 and 28 weeks pregnant. They should have internet access and a low score on a depression screening tool, while also having at least one risk factor for depression, such as a past history of depression or high anxiety. However, fathers with serious mental health issues or thoughts of self-harm cannot take part in this study. Participants will have the opportunity to explore the HealthyDads website and provide feedback on their experience, helping to shape future resources for dads in need.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- Fathers-to-be who:
- • reside in Canada
- • able to communicate in French or English
- • gestational age of partner's pregnancy between 14-28 weeks
- • internet access
- • score \<12 on the EPDS
- • at least 1 risk factor for depression if they score \<6 on the EPDS: a) history of depression; b) elevated anxiety (score \>10 on the Generalized Anxiety Disorder 7-item (GAD-7) scale)116; or c) couple discord (established cutoff score \<13 on the 4-item Dyadic Adjustment Scale117 or Pittsburgh Sleep Quality Index global score \>5
- Exclusion Criteria:
- • suicidal ideation or intent
- • score ≥12 on the EPDS
- • having a severe psychiatric disorder as reported by the participant
About Mcgill University
McGill University, a prestigious research institution located in Montreal, Canada, is committed to advancing medical science through innovative clinical trials. Renowned for its rigorous academic standards and collaborative approach, McGill fosters a dynamic environment that integrates cutting-edge research with clinical practice. With a focus on improving patient outcomes, the university's clinical trials span a wide range of therapeutic areas, leveraging the expertise of its diverse faculty and state-of-the-art facilities. McGill University is dedicated to ethical research practices and the dissemination of knowledge, ensuring that findings contribute meaningfully to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported